The most extensively studied compounds are exenatide (Byetta [Amylin Pharmaceuticals, San Diego, CA], which has been approved by the US Food and Drug Administration [FDA] for the treatment of type 2 diabetes), liraglutide (Victoza [Novo Nordisk, Princeton, NJ], which has been submitted to the FDA for approval), sitaglitptin (Januvia [Abbott Laboratories, Abbott Park, IL], which has been approved by the FDA for type 2 diabetes), and vildagliptin (Galvus [Novo Nordisk, Princeton, NJ], which has been submitted to FDA)
Ozempic is a GLP-1 receptor agonist that activates receptors in the gut and brain
Gathering Your Essential Supplies Proper preparation is half the battle
May Improve Nonalcoholic Fatty Liver Disease Glutathione may help manage nonalcoholic fatty liver disease now called metabolic dysfunction-associated steatotic liver disease a condition where extra fat builds up in the liver